Shu-Ping Yeh

Title: Shu-Ping Yeh: Innovator in Antibody Research

Introduction

Shu-Ping Yeh is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents, his work has the potential to impact various medical treatments.

Latest Patents

Shu-Ping Yeh's latest patents include innovative approaches to targeting specific receptors in the human body. One of his notable patents is for anti-human PD-L1 antibodies and their uses. This patent describes an anti-PD-L1 antibody, or an antigen-binding fragment thereof, which comprises a heavy chain variable region with specific sequences. Additionally, he has developed humanized anti-human neurotensin receptor 1 antibodies and their uses. This patent outlines a method for treating diseases related to NTSR1 activity and signaling, along with a method or kit for detecting NTSR1 in a sample.

Career Highlights

Throughout his career, Shu-Ping Yeh has worked with esteemed organizations such as the Development Center for Biotechnology and the National Health Research Institutes. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Shu-Ping Yeh has collaborated with notable colleagues, including Cheng-Chou Yu and Shih-Rang Yang. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Shu-Ping Yeh is a distinguished inventor whose work in antibody research holds promise for future medical advancements. His contributions to the field exemplify the importance of innovation in biotechnology.